Lowering Blood Pressure, Raising Cancer Risk?: Evidence From Randomized Clinical Trials and Genetic Studies

Affiliations

¹ Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom; Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom; Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
² Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: pigeyrem@mcmaster.ca.

Editorial

Fahmida Mannan et al. JACC CardioOncol. 2025 Aug.

. 2025 Aug;7(5):624-626.

doi: 10.1016/j.jaccao.2025.04.004.

¹ Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom; Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom; Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
² Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: pigeyrem@mcmaster.ca.

No abstract available

Keywords: epidemiology; genetics; hypertension; ischemic disease; lifestyle risk factors; lung cancer; prevention; renal cell cancer.

Conflict of interest statement

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

1. Copland E., Canoy D., Nazarzadeh M., et al. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis. Lancet Oncol. 2021;22:558–570. - PMC - PubMed
1. Nazarzadeh M., Copland E., Smith Byrne K., et al. Blood pressure-lowering and risk of cancer: individual participant-level data meta-analysis and Mendelian randomization studies. JACC CardioOncol. 2025;7(5):609–623. - PMC - PubMed
1. Sipahi I., Debanne S.M., Rowland D.Y., Simon D.I., Fang J.C. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 2010;11:627–636. - PMC - PubMed
1. Chan I.I., Kwok M.K., Schooling C.M. Blood pressure and risk of cancer: a Mendelian randomization study. BMC Cancer. 2021;21:1338. - PMC - PubMed
1. Davies N.M., Holmes M.V., Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362